Enfamil NeuroPro Study

Launched by UNIVERSITY OF ARIZONA · Sep 22, 2023

Keywords

ClinConnect Summary

The Enfamil NeuroPro Study is looking at how different types of infant feeding affect the bacteria in babies’ guts, which can play a role in their development. The study will compare three groups of infants: those who are fed a standard infant formula called Enfamil Infant, those who are fed a new formula designed to be closer to breast milk called Enfamil NeuroPro, and those who are breastfed. All of these formulas are safe and meet the requirements set by the FDA.

To participate in this study, infants must be healthy, full-term babies and their parents need to agree to take part. Parents should have a smartphone and be willing to answer weekly online questions about their baby’s feeding. However, babies who were born prematurely, through a C-section, have health issues, or are receiving both breast milk and formula are not eligible. If you decide to join, you will help researchers learn more about how different feeding methods can impact infant gut health and overall development.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy term infants with parental consent
• • Parents are able to provide informed consent; own a smart phone and are able to fill out weekly digital questionnaires.
• Exclusion Criteria:
• • Prematurity (\<= 36 weeks gestational age)
• • Babies born through c-section
• • Any health issues identified at the first postpartum screening
• • Use of both breast milk and formula
• • Use of donor breast milk
• • Parent unwillingness/inability to avoid giving prebiotics, probiotics, symbiotics, and immune-stimulating products to the child for the duration of this study